
Chief Executive Officer
Dr. Soudabeh Djalali Motlagh
Anesthesiology · Clinical leadership
LinkedInAnticoag360+ brings medical expertise and software development together around a practical question: how can complex anticoagulation guidance become easier to navigate?
The concept emerged from the experience of clinicians managing patients on anticoagulants, including around surgery and other time-sensitive decisions.
The founding team combined expertise in anaesthesiology, cardiology, healthcare operations and software development. Successive versions of the application have been refined through testing and clinician feedback in Iran, alongside professional engagement in Canada and internationally.
The next stage focuses on continued product refinement and Canada-first market preparation, with clinical, technical and regulatory requirements evaluated as part of that work.

Chief Executive Officer
Anesthesiology · Clinical leadership
LinkedIn
Chief Scientific Officer
Cardiology · Interventional electrophysiology
LinkedIn
Chief Operating Officer
Anesthesiology · Clinical operations
LinkedIn
Chief Marketing Officer
Healthcare business development
LinkedIn
Chief Technology Officer
Software development · Technical leadership
LinkedInMilestones below reflect company records through February 2026.
Development and multi-stage pilot work in Iran established the foundation for the clinician-facing workflow.
Physicians in family medicine, anaesthesia and dentistry provided feedback on practical relevance and usability.
An application was filed on 19 August 2025 and progressed to patentability assessment. An application is not a granted patent.
A paid agreement with Nikan Hospital Group in Iran provided an early commercial milestone.
An expanded bleeding-management workflow and updated Canadian market research informed the next development stage.
Explore the platform with our team, share clinical feedback, or discuss a research or institutional collaboration.